Innoser Is A European Contract Research Organizationcrobased In The Netherlands And Belgiumspecializing In Preclinical Drug Development Servicesfounded In 2012Innoser Operates Aaalac Accredited Facilities And Focuses On Supporting Biotechpharmaceuticaland Startup Clientsthe Company Aims To Accelerate Preclinical Research Using Validated Disease Models And Advanced Technologies Innoser Offers A Range Of Servicesincluding In Vivo Studiesin Vitro Servicesand Digital Pathology For Tissue Analysisthey Provide Specialized Models For Various Disease Areas Such As Oncologyimmunologyand Rare Genetic Disordersadditionallyinnoser Supports Clients With Contract Breedingcolony Managementand Facility Rentalsthe Company Also Features Proprietary Platforms Like Pdx Screening Tools And Cryo Preservation Solutions For Genetically Engineered Strainswith A Commitment To Innovationinnoser Integrates Technologies Like Real Time Imaging And Ai Driven Pathology Into Its Workflowstheir Facilities Are Designed For Studies Across Infectious Diseases And Complex Genetic Modelsensuring High Ethical Standards And Flexible Partnerships Tailored To Client Needs
